| Item |
Information |
|
Drug Groups
|
withdrawn |
|
Description
|
Zomepirac, formerly marketed as Zomax tablets, was associated with fatal and near-fatal anaphylactoid reactions. The manufacturer voluntarily removed Zomax tablets from the Canadian, US, and UK markets in March 1983. |
| Indication |
Zomepirac was indicated for the management of mild to severe pain. |
| Affected Organisms |
| • |
Humans and other mammals |
|
| External Links |
|
|